Apical hypertrophic cardiomyopathy is a rare variant that can be accurately diagnosed using cardiac MRI and managed symptomatically with beta blockers, alongside annual risk stratification for sudden cardiac death.
May support beta-blocker management without ICD in apical HCM; leaves open need for cohort validation of risk stratification.
Apical hypertrophic cardiomyopathy (HCM) is a rare variant of HCM. We present the case of a 26-years-old female who was diagnosed with apical HCM. Her electrocardiogram showed the characteristic T-wave inversions in V2-V5 and her echocardiogram portrayed apical left ventricular hypertrophy. The diagnosis was confirmed with a cardiac magnetic resonance imaging (MRI) scan. She was treated with beta blockers. Our case emphasizes that apical HCM is a relatively benign disease. However, due to the emerging evidence of sudden cardiac deaths in these patients, the risk for sudden death needs to be evaluated.
No takes yet. Share an insight, caveat, or question.
Khalid et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: